Clinical outcome of wild-type AmpC-producing Enterobacterales infection in critically ill patients treated with β-lactams: a prospective multicenter study

BACKGROUND: β-lactams are the main antibiotics used against wild-type AmpC-producing Enterobacterales (wtAE). However, they may fail or select AmpC-overproducing mutants. Our aim was to assess factors associated with clinical failure of β-lactams in the treatment of wtAE infection. METHODS: From Sep...

Descripción completa

Detalles Bibliográficos
Autores principales: Mounier, Roman, Le Guen, Ronan, Woerther, Paul-Louis, Nacher, Mathieu, Bonnefon, Clément, Mongardon, Nicolas, Langeron, Olivier, Levesque, Eric, Couffin, Séverine, Houcke, Stéphanie, Wolff, Michel, Roujansky, Ariane, Schimpf, Caroline, Mekontso Dessap, Armand, Cook, Fabrice, Razazi, Keyvan, Kallel, Hatem
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9672193/
https://www.ncbi.nlm.nih.gov/pubmed/36394673
http://dx.doi.org/10.1186/s13613-022-01079-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9672193/
https://www.ncbi.nlm.nih.gov/pubmed/36394673
http://dx.doi.org/10.1186/s13613-022-01079-5

Ejemplares similares